News Focus
News Focus
Replies to #3442 on Biotech Values
icon url

rkrw

08/30/04 6:52 PM

#3444 RE: DewDiligence #3442

<<Absolutely correct; that’s an area badly in need of reform:>>

Dew, you're a lot tougher than I would be!
icon url

Biopharm investor

08/31/04 8:05 AM

#3449 RE: DewDiligence #3442

Loopholes

I don't agree that the FTF status is a "loophole".

I think a bigger issue is the parking of exclusivity that comes with FTF status. This prevents the opening of a market for a given drug, costing consumers millions.